INTRODUCTION

150
The prevalence of asthma has dramatically increased over the past decades in high-income 151 countries, affecting 5-16% of people worldwide. 1 It is the most common chronic disease 152 among children and a decrease in the age-of-asthma onset has been recently documented.
2
153
Asthma is a complex and heterogeneous disease with variable clinical expression over the life 154 span. 1 It is now well recognized that asthma is not a single disease but rather a collection of 155 different phenotypes which may represent different manifestations of a common underlying 156 pathological process or may be separate disease entities. 3 One of the simplest characteristic 157 that can be used to differentiate disease phenotypes is the age at onset. 4 ,5 Indeed, asthma 158 displays different characteristics according to the lifetime period at which it occurs. 6 Early age
159
of onset is more frequently associated with a family history of asthma, allergy sensitization 160 and clinical response to triggers, whereas late-onset disease is associated with eosinophilic 161 inflammation and obesity, is more common in women, and is generally less allergic.
3
162
The risk of developing asthma has a strong genetic component, with estimated heritability 163 ranging from 35 to 95%. 7 Genome-wide association studies (GWASs) have been successful in 164 identifying more than 20 loci associated with asthma. 8 However, the genetic factors identified 165 to date account only for a small part of the genetic component of the disease. 1 This hidden 166 heritability might be linked to the phenotypic heterogeneity of asthma. 9 The vast majority of revealed two regions, 1p31 and 5q13, potentially linked to this phenotype. 10 A single GWAS 171 has been performed on age-of-asthma onset in asthmatic children and led to the identification 172 of two loci, not found by the previous asthma GWASs; these loci on chromosomes 3p26 and 173 11q24 were associated with an earlier onset of childhood asthma. 11 Moreover, the effect of 174 17q12-q21 genetic variants, identified by the first GWAS of asthma, 12 was found to be 175 restricted to early-onset asthma.
13,14
176
Instead of stratifying the data according to age-of-onset of disease using an arbitrary 177 threshold, one can integrate the age-of-onset in modeling asthma risk, by using survival 178 analysis methodology applied to both asthmatic and non-asthmatic subjects. 
METHODS
184
Populations
185
We studied 13,886 individuals of European ancestry from nine independent studies (one birth 186 cohort, five population-based and three family studies) which were part of the GABRIEL
187
European consortium on the genetics of asthma. 14 A brief description of these studies with 188 appropriate references is provided in the online repository and in quantitative trait loci (eQTLs). We used existing eQTL databases in multiple tissues
247
(especially blood and lung) for populations of European ancestry (see online repository).
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248
Functional annotations of significant SNPs (or their proxies) were obtained using 
Relationship of TAO-associated loci with age-of-asthma onset
252
In a first step, we investigated in asthmatics whether each of the SNPs associated with TAO
253
were also associated with age-of-asthma onset using a non-parametric rank test followed by a 254 non-parametric equality-of-medians test. In a second step, we assessed the cumulative effect 
RESULTS
264
Description of populations
265
A total of 13,886 subjects were included in the present study (5,462 asthmatics and 8,424
266 non-asthmatics). Asthmatics had a mean age-of-asthma onset of 12.5 years (ranging from 0.5 267 to 75 years, Figure E1 ), a mean age of 26.8 years at examination (mean per study ranging 268 from 9.1 to 51.3 years) and 52.6% were males. Non-asthmatics had a mean age of 32.4 years 269 at examination (mean per study ranging from 8.9 to 55.8 years) and 49% were males ( Table   270 E1).
272
Genetic variants associated with time-to-asthma onset
273
The Manhattan and the Q-Q plots of the meta-analysis of time-to-asthma onset GWAS results
274
are shown in Figure 1 and Figure E2 in the online repository respectively. A total of 155
275
SNPs were associated with time-to-asthma onset at the genome-wide significance level of 276 P<5x10 -8 . These SNPs clustered into five distinct chromosomal regions (Table I) in the primary meta-analysis). In contrast, at 2q12, 6p21 and 16q12 regions, the inclusion of 293 the most significant time-to-asthma onset GWAS SNP as a covariate in association analysis 294 resulted in nearly complete reduction of the association signal in these regions, suggesting 295 that there was no evidence for a second distinct genetic factor in these regions.
296
To obtain a denser map of the new TAO 16q12 locus, we repeated association analyses using Relationship between TAO-associated variants and age-of-asthma onset
323
To investigate whether TAO-associated SNPs influence the age-of-asthma onset, we 324 compared, in asthmatics, the distribution of age-of-asthma onset according to the number of 325 risk alleles at each of the seven main and secondary TAO-associated SNPs (Figure 3 ).
326
Asthmatic subjects carrying one or two copies of risk allele at 17q12-q21 SNPs (rs9901146 327 and rs3859192) or at 9p24 rs928413 had a younger age-of-asthma onset than non-carriers
328
(median 6-8 years versus 10 years (P≤6x10 -4 ) and median 6-8 years versus 9 years (P=0.002), 329 respectively), whereas those having at least one copy of rs1861760 risk-allele at 16q12 had a 330 later age-of-asthma onset than non-carriers (median 10 years versus 8 years; P=0.04). No 331 significant difference was found for the other three SNPs. We evidenced that an increased 332 number of risk alleles at these four SNPs was associated with a younger age-of-asthma onset
333
(median 12 years for carrying one risk allele to 4 years for carrying 6-8 risk alleles; P=10 -4 ).
334
Finally, we detected a strong association between the age-of-asthma onset and the polygenic 335 risk score (from median 10 years in first quintile to 6 years in last quintile; P=4x10 -4 ).
337
Comparison of time-to-asthma onset GWAS results with previous asthma GWASs
338
To investigate the impact of taking into account the age-of-asthma onset in disease modeling 339 through survival analysis, we explored whether the top TAO SNPs were associated with 340 asthma modeled as a binary trait in the nine cohorts included in the present study (Table E4 , 341 see online repository). We also investigated GABRIEL top SNPs in TAO meta-analysis 342 (Table E4) were strongly associated with an earlier onset of childhood asthma whereas the 16q12 lead
370
SNP was associated with a risk of later onset asthma.
371
The most significant 16q12 genetic variant (rs1861760) is located nearby CYLD and NOD2
372
and also maps to a binding site of FOXJ1, a transcription factor associated with allergic 373 rhinitis. 29 Genetic variants located in a 130-kb region around rs1861760 were reported Defining the phenotype is an important consideration because phenotypic heterogeneity can 399 reduce power of GWAS. 44 In the present analyses, we studied the variability of time-to- either adults or children).
424
It was suggested that some genetic variants might influence asthma in an age-specific manner.
425
Among TAO-associated SNPs, we confirmed the association of 17q12-q21 SNPs with an 426 early age-of-asthma onset 13, 14 and evidenced for the first time that the top 9p24 genetic variant 427 near IL33 was also associated with early childhood-onset asthma (median age-of-onset of 6-8 428 years in risk-allele carriers). Indeed, in GABRIEL meta-analysis, 9p24 SNPs were more 429 strongly associated with early-onset asthma (before 16 years) than late-onset asthma (after 16 430 years), but this difference was not significant. 14 Conversely, genetic variants at the new 431 susceptibility locus, 16q12, conferred a risk of later onset asthma (median age-of-onset of 10 432 years in risk-allele carriers). Moreover, we evidenced that a high burden of disease risk alleles 433 at these loci is associated with earlier age-of-asthma onset (4 years versus 9-12 years). This 434 difference in asthma onset may reflect difference in patterns of onset of disease. 47 Indeed, we 435 evidenced in the GABRIELA study that persistent early wheezing subjects carried more risk 436 alleles than transient early wheezing subjects, and we confirmed previous association between 437 persistent early wheezing and 9p24 and 17q12-q21 loci (data not shown 
